This Crypto Is Set to Explode in December

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Giovani Twigge Biography and Net Worth

SVP of IDEXX Laboratories

Mr. Twigge has been our Chief Human Resources Officer since August 2010, and leads worldwide human resources. Prior to joining us, from 1999 to 2010, Mr. Twigge held various human resources leadership positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products, and diagnostics, and was Divisional Vice President, HR, for Abbott Diagnostics. Prior to that, he served as Divisional Vice President, HR, for Abbott Nutrition International and as Regional HR Director for a number of international operations, including those in Europe, Latin America/Canada and the Middle East. Mr. Twigge earned his B. Commerce (Honors) degree in personnel management from the University of Pretoria, South Africa.

What is Giovani Twigge's net worth?: The estimated net worth of Giovani Twigge is at least $5.86 million as of August 31st, 2020. Mr. Twigge owns 14,222 shares of IDEXX Laboratories stock worth more than $5,863,162 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Twigge may own. Learn More about Giovani Twigge's net worth.
How do I contact Giovani Twigge?: The corporate mailing address for Mr. Twigge and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]. Learn More on Giovani Twigge's contact information.
Has Giovani Twigge been buying or selling shares of IDEXX Laboratories?: Giovani Twigge has not been actively trading shares of IDEXX Laboratories during the last ninety days. Most recently, Giovani Twigge sold 11,421 shares of the business's stock in a transaction on Wednesday, August 4th. The shares were sold at an average price of $700.35, for a transaction totalling $7,998,697.35. Learn More on Giovani Twigge's trading history.
Who are IDEXX Laboratories' active insiders?: IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), George Fennell (SVP), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.
Are insiders buying or selling shares of IDEXX Laboratories?: During the last year, insiders at the sold shares 5 times. They sold a total of 44,068 shares worth more than $25,124,750.88. The most recent insider tranaction occured on November, 27th when Director Sophie V Vandebroek sold 344 shares worth more than $144,631.36. Insiders at IDEXX Laboratories own 2.1% of the company. Learn More about insider trades at IDEXX Laboratories.
Information on this page was last updated on 11/27/2024.

Giovani Twigge Insider Trading History at IDEXX Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/4/2021	Sell	11,421	$700.35	$7,998,697.35
11/30/2020	Sell	12,801	$456.49	$5,843,528.49
8/31/2020	Sell	7,316	$388.19	$2,839,998.04	14,222
8/28/2020	Sell	18,038	$386.19	$6,966,095.22
5/29/2020	Sell	14,070	$307.73	$4,329,761.10
11/29/2019	Sell	14,750	$250.51	$3,695,022.50
8/9/2019	Sell	2,300	$274.44	$631,212.00
5/31/2019	Sell	2,600	$250.14	$650,364.00	12,595
5/6/2019	Sell	2,015	$250.00	$503,750.00
2/28/2019	Sell	1,500	$211.77	$317,655.00
2/6/2019	Sell	997	$209.08	$208,452.76
5/29/2018	Sell	1,626	$204.37	$332,305.62
11/30/2017	Sell	2,000	$156.07	$312,140.00
5/31/2017	Sell	2,572	$166.90	$429,266.80

Giovani Twigge Buying and Selling Activity at IDEXX Laboratories

IDEXX Laboratories Company Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Today's Range

Now: $412.26

$404.36

$418.26

50 Day Range

MA: $433.90

$406.92

$478.00

2 Week Range

Now: $412.26

$398.50

$583.39

Volume

1,122,179 shs

Average Volume

516,185 shs

Market Capitalization

$33.76 billion

P/E Ratio

39.76

Dividend Yield

N/A

Beta

1.37

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad